CeNeRx BioPharma

News

Peripheral neuropathy treatment gets FDA OK for clinical trials

CeNeRx BioPharma's investigational new drug application on a compound aimed at treating peripheral neuropathy has been approved by the U.S. Food and Drug Administration. The Cary, North Carolina-based company is now preparing to move forward in human trials of the compound.

By Frank Vinluan

News

CeNeRx BioPharma raises $13M for trial of antidepression drug

CeNeRx BioPharma has raised a $13 million Series C round of financing that will fund phase 2 clinical trials of its antidepressant drug candidate.

By Brandon Glenn

With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?

Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.